Answers are grounded in this paper and cite their sources.
Lung cancer is one of the most common and fatal malignant tumors globally. Hypoxia, glycolysis, and lactylation modification are interconnected and critical for tumor progression, but the prognostic role of hypoxia-, glycolysis-, and lactylation- genes (HGLRGs) in lung adenocarcinoma (LUAD) and the biological functions of key genes remain unclear. We obtained LUAD patients’ gene expression profiles and clinical data from TCGA and GEO databases, established and validated an HGLRG-based prognostic model using differential expression analysis, Cox and Lasso regression. We further evaluated the model’s value in clinical prognosis, immune regulation, gene mutation, and treatment response prediction. The oncogenic function of B4GALT4 was investigated by lentiviral-mediated knockdown and overexpression in LUAD cells, followed by bidirectional rescue experiments using the LDHA inhibitor FX11 to block lactate production and exogenous sodium L-lactate to restore it. A prognostic signature with six HGLRGs (ALDOA, ANGPTL4, BCAN, ENO3, FBP1, B4GALT4) was constructed from TCGA and validated in GSE68465, which was an independent risk factor for LUAD patients’ overall survival and had good discriminative ability. The high- and low-risk groups exhibited significant differences in genetic mutation profiles, immune microenvironment, and prediction of therapeutic response. B4GALT4 was the prognostic candidate, whose knockdown significantly inhibited LUAD cell proliferation, clonogenesis, invasion and migration, and it increased LUAD cell lactylation by enhancing glucose uptake and lactate production. Bidirectional rescue experiments demonstrated that FX11-mediated inhibition of lactate production abolished B4GALT4 overexpression-induced malignant phenotypes, whereas exogenous lactate supplementation restored the phenotypes suppressed by B4GALT4 knockdown, with coordinated changes in histone lactylation. This study identified HGLRG-based LUAD prognostic system, revealing B4GALT4 regulates lactylation via metabolic remodeling, providing new basis for LUAD prognosis and targeted research.
No takes yet. Share an insight, caveat, or question.
Fang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: